The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Official Title: Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Study ID: NCT00232128
Brief Summary: This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.
Detailed Description:
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Comprehensive Cancer Institute, Huntsville, Alabama, United States
Name: Marshall T. Schreeder, M.D.
Affiliation: Comprehensive Cancer Institute
Role: PRINCIPAL_INVESTIGATOR